Stocks and Investing Stocks and Investing
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Sandvine Adds New Board Member
[ Wed, Oct 12th 2011 ] - Market Wire
BMO Economics

BIOTECHNOLOGY Stocks Expected To Be Up After Top Correlated Stocks Fire Buy Signals.


Published on 2011-10-12 07:00:30 - WOPRAI
  Print publication without navigation


October 12, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring the top most highly correlated BIOTECHNOLOGY stocks and the majority have fired a Buy signal as of today. ISHARES NASDAQ BIOTECH INDX (NASDAQ:IBB), DENDREON CORP (NASDAQ:DNDN), HEMISPHERX BIOPHARMA INC (AMEX:HEB), ENZON PHARMACEUTICALS INC (NASDAQ:ENZN), BIOTECH HOLDRS TRUST (NYSE:BBH), SPDR S&P BIOTECH ETF (NYSE:XBI) are all expected to be Up as the top stocks in the sector have fired Buy signals. Group rotation is a phenomenon where institutions exert buying or selling pressure in an industry group, pushing prices of the group higher or higher relative to the general market. An industry can often lead or lag the market, and the most highly correlated stocks (mirror closest to the overall move in that group) usually move in unison. The technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The chart below displays the correlation, beta and relative strength of the top most highly correlated stocks in the highlighted industry group:

     Symbol     Company                             Correlation     Beta        RelStr      Sector 
     IBB        ISHARES NASDAQ BIOTECH INDX         0.96            0.78        1           BIOTECHNOLOGY
     DNDN       DENDREON CORP                       0.75            4.54        0.92        BIOTECHNOLOGY
     HEB        HEMISPHERX BIOPHARMA INC            0.73            0.95        0.81        BIOTECHNOLOGY
     ENZN       ENZON PHARMACEUTICALS INC           0.8             1.17        0.98        BIOTECHNOLOGY
     BBH        BIOTECH HOLDRS TRUST                0.8             0.15        1.01        BIOTECHNOLOGY
     XBI        SPDR S&P BIOTECH ETF                0.93            0.8         1.02        BIOTECHNOLOGY
We automatically calculate correlation to help find the stocks that most closely match their groups movement and generate powerful group consensus trading signals to profit from the herd mentality. When multiple stocks in a group turn at the same time and the rotation of that group is confirmed, an explosive move typically occurs. Correlation measures the tendency for a symbol to move in unison with the group, beta measures the amount the symbol is expected to move relative to the group and relative strength looks back at the recent past to show how the stock has been moving relative to the group.

ISHARES NASDAQ BIOTECH INDX (NASDAQ:IBB) - ISHARE NQ BIOTCH

DENDREON CORP (NASDAQ:DNDN) - Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. The company offers active cellular immunotherapy and small molecule product candidates to treat various cancers. Its product candidates comprise Provenge (sipuleucel-T), an active cellular immunotherapy for the treatment of metastatic, castrate-resistant prostate cancer; DN24-02, an investigational active immunotherapy for the treatment of patients with bladder, breast, ovarian, and other solid tumors expressing HER2/neu; and TRPM8, a small molecule agonist to transient receptor potential ion channel, for multiple cancers. The company also has a range of products in preclinical studies, which include Carcinoembryonic antigen for the treatment of lung, colon, and breast cancer; and Carbonic AnhydraseIX for the treatment of kidney cancer. Dendreon Corporation was founded in 1992 and is headquartered in Seattle, Washington.

HEMISPHERX BIOPHARMA INC (AMEX:HEB) - Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The companys products include Ampligen, an experimental drug that is under clinical development for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome, Hepatitis B, human immunodeficiency virus, renal cell carcinoma, and malignant melanoma; and Alferon N Injection for the treatment of genital warts. Its products also comprise Alferon LDO, a low-dose, oral liquid formulation of natural alpha interferon for influenza and other emerging viral diseases; and Oragens, a set of oral broad spectrum antivirals and immunological enhancers for the treatment of chronic viral and immunological disorders. The company has a strategic alliance with Accredo to develop certain marketing and distribution capacities for Ampligen in the United States. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.

ENZON PHARMACEUTICALS INC (NASDAQ:ENZN) - Enzon Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines for patients with cancer primarily in the United States and Europe. Its drug development program utilizes Customized Linker technology and the Locked Nucleic Acid technology. The companys development product pipeline consists of PEG-SN38 compound that utilizes PEGylation technology for the treatment of colorectal, breast, and pancreatic cancer, as well as for non-Hodgkins lymphoma; and hypoxia-inducible factor 1 alpha antagonist for the treatment of cancers, including common solid tumors. Its product line also comprises Survivin Antagonist that plays a regulatory role in both apoptosis and cell division. The company also licenses its PEGylation platform for various products, such as PEG-INTRON, Macugen, and CIMZIA. Enzon Pharmaceuticals, Inc. was founded in 1981 and is based in Bridgewater, New Jersey.

BIOTECH HOLDRS TRUST (NYSE:BBH) - Ml Biotech Hldr

SPDR S&P BIOTECH ETF (NYSE:XBI) - SPDR BIOTECH ETF

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net